If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
108.20    0.80 (0.74%)
Bid:
107.20
Ask:
108.00
Spread: 0.80 (0.746%)
Market Cap: £658.06m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director/PDMR Shareholding

27 Mar 2019 11:12

RNS Number : 1827U
Syncona Limited
27 March 2019
 

Syncona Limited

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

 

27 March 2019

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Nicholas Moss

b)

Position / status

Senior Independent Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares

GG00B8P59C08

 

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.497

8,004

d)

Aggregated information

Aggregated volume

Price

 N/A

e)

Date of the transaction

22 March 2019

f)

Place of the transaction

London Stock Exchange

g)

Currency

GBP - British Pound

 

 

[ENDS]

 

Enquiries

Syncona Ltd

Annabel Clay

Tel: +44 (0) 20 7611 2031

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBRARKKAOUAR
Date   Source Headline
9th Jul 20201:00 pmRNSIssue of shares pursuant to Incentive Scheme
30th Jun 20207:00 amRNSFreeline announces additional financing plans
30th Jun 20207:00 amRNSFreeline expands Series C financing to $120million
25th Jun 202012:38 pmRNSAnnual Financial Report
18th Jun 202012:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSKemal Malik Appointed as Non-Executive Director
12th Jun 20207:36 amRNSAutolus AUTO1 and AUTO3 data at EHA
11th Jun 20207:00 amRNSFinal Results
29th May 202012:49 pmRNSAutolus presents additional data on AUTO3 in DLBCL
29th May 20207:05 amRNSFirst patient dosed in Achilles’ melanoma study
20th May 20209:24 amRNSNotice of Results
7th May 202012:15 pmRNSAutolus reports Q1 2020 Financial Results
23rd Apr 20207:00 amRNSNew commitment to SwanBio
16th Apr 202012:10 pmRNSAutolus announces acceptance of IND application
31st Mar 20201:26 pmRNSDirector/PDMR Shareholding
26th Mar 20209:41 amRNSStandard form for notification of major holdings
23rd Mar 20207:00 amRNSBusiness Update
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20201:53 pmRNSDirector/PDMR Shareholding
5th Mar 202011:14 amRNSDirector/PDMR Shareholding
3rd Mar 202012:29 pmRNSAutolus reports Q4 2019 Financial Results
12th Feb 20202:00 pmRNSFreeline presents clinical data at WORLDSymposium
7th Feb 20201:24 pmRNSFreeline publishes further data for FLT180a
4th Feb 20207:00 amRNSQuarterly Update
30th Jan 202012:08 pmRNSAutolus announces additional data in AUTO3 at EHA
23rd Jan 20207:00 amRNSAutolus announces pricing of public offering
21st Jan 202012:01 pmRNSFreeline to present further FLT180a data at EAHAD
21st Jan 20208:45 amRNSNotice of Capital Markets Day
19th Dec 20197:00 amRNSSyncona makes further $80m commitment to Freeline
9th Dec 20197:00 amRNSAutolus announces new data at ASH Annual Meeting
9th Dec 20197:00 amRNSAutolus announces new data in AUTO3 at ASH
21st Nov 20197:00 amRNSSyncona leads £32 million financing in Azeria
21st Nov 20197:00 amRNSInterim Results
11th Nov 20199:00 amRNSNotice of Results
7th Nov 201912:32 pmRNSAutolus reports Q3 2019 Financial Results
6th Nov 20192:20 pmRNSAutolus to Present New Data at the ASH Meeting
6th Nov 20192:13 pmRNSFreeline presents pre-clinical data at ASH meeting
3rd Sep 20197:00 amRNSSyncona cornerstones £100m financing in Achilles
3rd Sep 20197:00 amRNSSyncona makes £48 million commitment to Gyroscope
12th Aug 20197:00 amRNSQuarterly Update
8th Aug 201912:59 pmRNSAutolus reports Q2 2019 Financial Results
1st Aug 20197:00 amRNSCompletion of sale of Blue Earth Diagnostics
31st Jul 201912:24 pmRNSTotal Voting Rights
30th Jul 201911:55 amRNSResult of AGM
18th Jul 20193:51 pmRNSIssue of shares per 2019 dividend & PDMR dealings
11th Jul 201911:21 amRNSIssue of shares pursuant to LTIP and PDMR dealings
8th Jul 20197:00 amRNSFreeline provides 12 month Haemophilia B data
28th Jun 201912:33 pmRNS2019 Dividend Scrip Reference Price
27th Jun 201911:44 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.